The Effect of Tear Supplements on Contact Lens Comfort
NCT02956083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2016-11-04
Summary
The primary goal of this investigation is to determine if lipid based artificial tear supplementation has an impact on contact lens discomfort (CLD).
Conditions
- Dry Eye Syndromes
- Meibomian Gland Dysfunction
Interventions
- OTHER
-
Systane Balance eye drops
Propylene Glycol 0.6% Over the counter lipid based artificial tears.
- OTHER
-
Systane Contacts eye drops
Hydroxypropyl methycellulose over the counter non-lipid based artificial tears
- OTHER
-
saline
Saline - no brand name
Sponsors & Collaborators
-
University of the Incarnate Word
lead OTHER
Principal Investigators
-
Srihari Narayanan, OD, PhD · University of the Incarnate Word
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
More Related Trials
-
Direct Application of Systane Complete to Contact Lenses
NCT03848221 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
NCT00938951 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes
NCT00781092 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of SYSTANE Ultra Lubricant Eye Drops
NCT00702377 ·Status: COMPLETED ·Phase: NA
-
Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes
NCT02806921 ·Status: COMPLETED ·Phase: NA
-
Acute Comfort and Blur of Systane and Optive
NCT00568386 ·Status: COMPLETED ·Phase: NA
-
Tears Substitutions and Their Effects on Higher Order Aberrometery
NCT00812721 ·Status: WITHDRAWN ·Phase: NA
-
The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye Subjects
NCT00553579 ·Status: COMPLETED
-
Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance
NCT01589640 ·Status: UNKNOWN
-
Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use
NCT00347984 ·Status: COMPLETED ·Phase: NA
-
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops
NCT03706443 ·Status: COMPLETED ·Phase: NA
-
An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens Discomfort
NCT03733899 ·Status: COMPLETED ·Phase: NA
-
SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers
NCT01733732 ·Status: COMPLETED ·Phase: NA
-
The Effect of Systane Ultra Lubricant Eye Drops (FID 112903) on Visual Performance
NCT00673764 ·Status: COMPLETED ·Phase: NA
-
Treating Contact Lens Discomfort With Orthokeratology
NCT03566680 ·Status: COMPLETED ·Phase: NA
-
Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber
NCT01482312 ·Status: COMPLETED ·Phase: NA
-
In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients
NCT01483989 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the Causes of Contact Lens Related Dry Eye
NCT00995189 ·Status: COMPLETED ·Phase: NA
-
Formula Identification (FID) 114657 in Contact Lens Wearers
NCT02293538 ·Status: COMPLETED ·Phase: NA
-
The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
NCT00395759 ·Status: COMPLETED ·Phase: NA
-
Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision
NCT00627302 ·Status: COMPLETED ·Phase: PHASE4
-
Autologous Serum Eye Drops With Contact Lenses for Corneal Epithelial Defects
NCT02291731 ·Status: COMPLETED ·Phase: NA
-
Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery
NCT06763731 ·Status: RECRUITING ·Phase: PHASE4
-
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
NCT01132287 ·Status: COMPLETED ·Phase: NA
-
A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients
NCT01311609 ·Status: COMPLETED ·Phase: PHASE4